Zunyi Medical University

Editorial: The Clinical Application of Neoantigens (2022) Zhou JG, Ding Z, Shi H, Cheng M Journal article, Editorial Identification of an endogenous retroviral signature to predict PD-1 blockade response in advanced clear cell renal cell carcinoma: Integrated analysis of three clinical trials (2021) Zhou JG, Wang H, Ma H, Gaipl U Conference contribution EARLY BLOOD CELL COUNT TEST (BCT) FOR SURVIVAL PREDICTION FOR NON-SMALL CELL LUNG CANCER PATIENTS TREATED WITH ATEZOLIZUMAB: INTEGRATED ANALYSIS OF 4 MULTICENTER CLINICAL TRIALS (2021) Zhou JG, Wong AHH, Wang H, Jin SH, Tan F, Chen YZ, He SS, et al. Conference contribution Dissecting Tumor Antigens and Immune Subtypes of Glioma to Develop mRNA Vaccine (2021) Zhong H, Liu S, Cao F, Zhao Y, Zhou J, Tang F, Peng Z, et al. Journal article Longitudinal C-reactive protein (CRP) as an individualized dynamic predictor for metastatic cancer patients treated with immune checkpoint inhibitors: Findings from the prospective ST-ICI cohort. (2021) Zhou JG, Ma H, Gaipl U, Frey B, Hecht M, Fietkau R Conference contribution Identification of 15 lncRNAs Signature for Predicting Survival Benefit of Advanced Melanoma Patients Treated with Anti-PD-1 Monotherapy (2021) Zhou JG, Liang B, Liu JG, Jin SH, He SS, Frey B, Gu N, et al. Journal article The Early Landscape of Immune Cell Subsets in Metastatic NSCLC Patients Treated with Immune Checkpoint Inhibitors (2021) Zhou J, Donaubauer AJ, Frey B, Becker I, Rutzner S, Sun R, Ma H, et al. Conference contribution Prospective development and validation of a liquid immune profile-based signature (LIPS) to predict response of patients with recurrent/metastatic cancer to immune checkpoint inhibitors (2021) Zhou J, Donaubauer AJ, Frey B, Becker I, Rutzner S, Eckstein M, Sun R, et al. Journal article, Review article Screening and validation of a novel T stage-lymph node ratio classification for operable colon cancer. (2021) Pei JP, Zhang R, Zhang NN, Zeng YJ, Sun Z, Ma SP, Zhou JG, et al. Journal article Establishment and Validation of a Prognostic Immune Signature in Neuroblastoma. (2021) Yu Y, Zeng Y, Xia X, Zhou JG, Cao F Journal article